UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by ARS Wealth Advisors Group LLC

ARS Wealth Advisors Group LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the fourth quarter, HoldingsChannel reports. The firm owned 27,646 shares of the healthcare conglomerate’s stock after purchasing an additional 165 shares during the quarter. UnitedHealth Group comprises about 1.9% of ARS Wealth Advisors Group LLC’s holdings, making the stock its 22nd largest holding. ARS Wealth Advisors Group LLC’s holdings in UnitedHealth Group were worth $13,985,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Delta Financial Group Inc. grew its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares during the last quarter. First PREMIER Bank grew its position in shares of UnitedHealth Group by 7.0% during the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 18 shares during the last quarter. Genesee Capital Advisors LLC lifted its position in UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC increased its stake in shares of UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the period. Finally, Matrix Private Capital Group LLC boosted its position in shares of UnitedHealth Group by 3.6% during the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 19 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH opened at $543.21 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a fifty day moving average price of $554.45 and a 200 day moving average price of $563.12. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $499.91 billion, a PE ratio of 35.39, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the business earned $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. TD Cowen increased their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Barclays boosted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.